ThomasManfredPfeifferMD

Pediatrics • Saint Louis, MO

Pediatric Hematology/Oncology

Assistant Professor

Join to view full profile

Dr. Pfeiffer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pfeiffer's full profile

Already have an account?

Office
1 Childrens Pl
# Div
Saint Louis, MO 63110
Phone+1 314-454-6043

Fax+1 888-463-6898

Education & Training

Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2018 - 2021
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 2015 - 2018
University of Vienna Faculty of MedicineClass of 2014, M.D.

Certifications & Licensure

MO State Medical License 2022 - 2026
IN State Medical License 2018 - 2019
OH State Medical License 2015 - 2018
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

1 citations
Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors.
Anne Miller, Rachel Daum, Tao Wang, Mengfen Wu, Candise Tat
Cytotherapy. 2024-09-01
Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantation.
Thomas Pfeiffer, Christine R Lockowitz, Shalini Shenoy, Melissa Mavers, Robert Hayashi
Bone Marrow Transplantation. 2024-08-01
3 citations
Virus-Specific T Cells for the Treatment of Systemic Infections Following Allogeneic Hematopoietic Cell and Solid Organ Transplantation.
Abby Green, Jeremy D Rubinstein, Michael Grimley, Thomas Pfeiffer
Journal of the Pediatric Infectious Diseases Society. 2024-02-28

Press Mentions

Study Finds Posoleucel Demonstrated Antiviral Efficacy and Safety Against Viral Infections Following Allogeneic Stem Cell TransplantationJanuary 13th, 2023
Investigational T-cell Therapy for Viral Infection After Allogeneic Stem Cell Transplant Shows 95% Patient ResponseJanuary 12th, 2023
AlloVir’s T-cell Therapy Smashes Viral Infections in Phase II TrialJanuary 11th, 2023
Join now to see all